Dr Jong Seo Kim, a highly experienced plastic surgeon known for his contributions to aesthetic medicine, will be presenting at the 2025 ASCD Symposium. His sessions will focus on periorbital rejuvenation and polynucleotide (PN) treatments, which are being explored for their potential in skin rejuvenation. Rejuran is one well-known type of PN treatment.

As the Managing Director of Dr. Jongseo Kim Plastic Surgery and Director of the KIM-Jong Seo Plastic Surgery Clinic in Gangnam, South Korea, Dr Kim has been actively involved in advancing facial bone contouring and minimally invasive rejuvenation techniques. Additionally, he leads the Botox-Filler-Thread Lifting Study Group of the Korean Plastic & Reconstructive Surgery Association.

Dr Kim’s contributions to the field include research in botulinum toxin applications, filler augmentation, and facial bone surgery.

At the 2025 ASCD Symposium, Dr. Kim will be delivering several key presentations:

Friday, 21 March – Workshop 2 | Masterclass on Periorbital Rejuvenation, Room B

  • 2:10 pm – 2:30 pm: Comprehensive Approaches to Periorbital Wrinkles – A discussion on PN injections using an injector, alongside RF and fractional laser techniques, fat removal, and lower eyelid surgery.
  • 3:50 pm – 4:10 pm: Sono Anatomy and Horizontal Neck Fold Treatment – Examining the use of Dermis HA PN to improve skin texture and elasticity.

Saturday, 22 March – Session 3A, Room A

  • 2:00 pm – 2:15 pm: A Decade of Polynucleotide Clinical Experience – Insights from over ten years of research into skin regeneration through various injection techniques. Learn more about PN here.
  • 2:45 pm – 3:00 pm: Histological Insights into Polynucleotides – Findings on how PN may support tissue regeneration, collagen production, and fibroblast activation in facial adipose and dermal layers. For more on Rejuran I, visit rejuran.com.au/pages/i

Dr Kim’s extensive experience in aesthetic medicine and clinical practice makes these sessions highly relevant for practitioners looking to enhance their treatment techniques.

For more information on Dr Jong Seo Kim and his work, visit surgery.co.kr

For more information on Rejuran, visit rejuran.com.au
For more information on the ASCD Symposium, visit ascd.org.au/2025-ascd-symposium/

About K Bridge Medical Pty Ltd

K Bridge Medical is a leading distributor of innovative aesthetic medical solutions in Australia, including the widely recognised Rejuran range. With a commitment to clinical excellence, K Bridge Medical provides Australian healthcare professionals with access to advanced medical technologies that enhance procedural outcomes.

Previous articleDr Jake Sloane to present on ‘Integrating Rejuran into Clinical Practice’
Next articleNew Profhilo Structura – pioneering regenerative aesthetics